« Zurück
Startseite /
Hyaluronidase, Bovine testes

Hyaluronidase, Bovine testes

ArtNr	HY-107910-100mg
Hersteller	MedChem Express
CAS-Nr.	37326-33-3
Menge	100 mg
Quantity options	100 mg 10 mMx1 mL 10 mg 25 mg 500 mg 50 mg 5 mg
Kategorie	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Bladder Cancer
Typ	Inhibitors
Specific against	other
Citations	[1]Vartanian AJ, et al. Injected hyaluronidase reduces restylane-mediated cutaneous augmentation. Arch Facial Plast Surg. 2005 Jul-Aug;7(4):231-7.\|[2]Brandon E, et al. The Use of Hyaluronidase in Cosmetic Dermatology: A Review of the Literature. J Clin Investigat Dermatol. 2015;3(2): 7.\|[3]Apaza Ticona L, et al. Rubus urticifolius Compounds with Antioxidant Activity, and Inhibition Potential against Tyrosinase, Melanin, Hyaluronidase, Elastase, and Collagenase[J]. Pharmaceuticals (Basel). 2024 Jul 13;17(7):937.\|[4]Jung H. Hyaluronidase: An overview of its properties, applications, and side effects[J]. Arch Plast Surg. 2020 Jul;47(4):297-300.\|[5]Lee W, et al. Comparative Effectiveness of Different Interventions of Perivascular Hyaluronidase[J]. Plast Reconstr Surg. 2020 Apr;145(4):957-964.\|[6]Wang M, et al. Comparison of Intra-arterial and Subcutaneous Testicular Hyaluronidase Injection Treatments and the Vascular Complications of Hyaluronic Acid Filler[J]. Dermatol Surg. 2017 Feb;43(2):246-254.\|[7] Kim DW, et al. Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management. J Plast Reconstr Aesthet Surg. 2011 Dec;64(12):1590-5. \|[8]Gong H, et al. Hyaluronidase To Enhance Nanoparticle-Based Photodynamic Tumor Therapy. Nano Lett. 2016 Apr 13;16(4):2512-21. Cell Biosci. 2023 Aug 10;13(1):147.\|Cell Oncol (Dordr). 2024 Dec 24.\|Drug Dev Ind Pharm. 2023 Mar 27;1-37.\|Mol Cancer. 2024 Jan 10;23(1):12.\|Nat Commun. 2023 May 26;14(1):3050.\|Theranostics. 2023; 13(6):2040-2056.\|Cell Death Dis. 2025 Mar 20;16(1):190.
Smiles	[Hyaluronidase, Bovine testes]
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Hyaluronate 4-glycanohydrolase,Bovine testes,Hyaluronoglucosaminidase,Bovine testes
Versandbedingung	Raumtemperatur
Lieferbar
Manufacturer - Type	Reference compound
Manufacturer - Targets	NF-κB
Shipping Temperature	Room Temperature
Storage Conditions	Store at 4°C for 2 years, protect from light
Molecular Weight	55000 (average)
Product Description	Hyaluronidase, Bovine testes (Hyaluronate 4-glycanohydrolase; Hyaluronoglucosaminidase) is an endoglycosidase that depolymerizes Hyaluronic acid (HA) (HY-B0633A) by cleavage of glycosidic bonds. Hyaluronidase degrades HA and activates membrane receptors that trigger pathways converging in NF-κB activation. Hyaluronidase is employed in the research of granulomatous foreign body reactions, soft-tissue necrosis caused by vascular compromise and uncomplicated nodules, overcorrection, inflamed nodules or tissue ischemia associated with HA filler injection[1][2][3][4][5][6].
Manufacturer - Research Area	Inflammation/Immunology; Cancer
Solubility	H2O: 100 mg/mL (ultrasonic)
Manufacturer - Pathway	NF-κB
Clinical information	Launched

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

HY-107910-100mg-safety-datasheet.pdf